chr19-17255416-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031941.4(USHBP1):c.1661G>A(p.Gly554Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031941.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USHBP1 | NM_031941.4 | c.1661G>A | p.Gly554Asp | missense_variant | Exon 10 of 13 | ENST00000252597.8 | NP_114147.2 | |
USHBP1 | NM_001321417.2 | c.1661G>A | p.Gly554Asp | missense_variant | Exon 10 of 13 | NP_001308346.1 | ||
USHBP1 | NM_001297703.2 | c.1469G>A | p.Gly490Asp | missense_variant | Exon 9 of 12 | NP_001284632.1 | ||
USHBP1 | NR_135632.2 | n.1902G>A | non_coding_transcript_exon_variant | Exon 11 of 14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USHBP1 | ENST00000252597.8 | c.1661G>A | p.Gly554Asp | missense_variant | Exon 10 of 13 | 1 | NM_031941.4 | ENSP00000252597.2 | ||
ENSG00000269095 | ENST00000594059.1 | c.-344G>A | 5_prime_UTR_variant | Exon 1 of 5 | 4 | ENSP00000473056.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1661G>A (p.G554D) alteration is located in exon 10 (coding exon 9) of the USHBP1 gene. This alteration results from a G to A substitution at nucleotide position 1661, causing the glycine (G) at amino acid position 554 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.